FR2909378A1 - New (pseudo)ceramide compounds useful in the field of hair care, like shampoos, after-shampoos, lotions or hair balms - Google Patents
New (pseudo)ceramide compounds useful in the field of hair care, like shampoos, after-shampoos, lotions or hair balms Download PDFInfo
- Publication number
- FR2909378A1 FR2909378A1 FR0610602A FR0610602A FR2909378A1 FR 2909378 A1 FR2909378 A1 FR 2909378A1 FR 0610602 A FR0610602 A FR 0610602A FR 0610602 A FR0610602 A FR 0610602A FR 2909378 A1 FR2909378 A1 FR 2909378A1
- Authority
- FR
- France
- Prior art keywords
- carbon atoms
- formula
- chosen
- hair
- ceramide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002453 shampoo Substances 0.000 title claims description 8
- 239000006210 lotion Substances 0.000 title claims description 4
- 235000010654 Melissa officinalis Nutrition 0.000 title claims description 3
- 239000000865 liniment Substances 0.000 title claims description 3
- 241000021559 Dicerandra Species 0.000 title claims 2
- 150000001783 ceramides Chemical class 0.000 title abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 19
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 15
- 239000002537 cosmetic Substances 0.000 claims abstract description 8
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 229910052794 bromium Inorganic materials 0.000 claims abstract description 6
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 6
- 125000003118 aryl group Chemical group 0.000 claims abstract description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims abstract description 3
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims abstract description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims abstract description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims description 34
- 229940106189 ceramide Drugs 0.000 claims description 26
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 21
- 125000004432 carbon atom Chemical group C* 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 16
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 14
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 11
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 11
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 11
- 230000015572 biosynthetic process Effects 0.000 claims description 10
- 229920006395 saturated elastomer Chemical group 0.000 claims description 10
- 238000003786 synthesis reaction Methods 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 239000000460 chlorine Substances 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 5
- 230000008878 coupling Effects 0.000 claims description 4
- 238000010168 coupling process Methods 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 claims description 3
- -1 hair conditioners Substances 0.000 claims description 3
- 239000012442 inert solvent Substances 0.000 claims description 3
- 231100000252 nontoxic Toxicity 0.000 claims description 3
- 230000003000 nontoxic effect Effects 0.000 claims description 3
- 101150035983 str1 gene Proteins 0.000 claims description 3
- 150000003512 tertiary amines Chemical class 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 239000012071 phase Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 150000001767 cationic compounds Chemical class 0.000 description 4
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000000230 xanthan gum Substances 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- 229940082509 xanthan gum Drugs 0.000 description 4
- 235000010493 xanthan gum Nutrition 0.000 description 4
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosanyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 244000271437 Bambusa arundinacea Species 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 description 2
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- 229940073499 decyl glucoside Drugs 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229940057874 phenyl trimethicone Drugs 0.000 description 2
- 229920002553 poly(2-methacrylolyloxyethyltrimethylammonium chloride) polymer Polymers 0.000 description 2
- 238000005956 quaternization reaction Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 2
- 229960000368 sulisobenzone Drugs 0.000 description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 2
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- KZVIUXKOLXVBPC-UHFFFAOYSA-N 16-methylheptadecanamide Chemical compound CC(C)CCCCCCCCCCCCCCC(N)=O KZVIUXKOLXVBPC-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- LWDBKTVFHPCKHL-UHFFFAOYSA-N 2-nonanoyloxypropyl nonanoate Chemical compound C(CCCCCCCC)(=O)OCC(C)OC(CCCCCCCC)=O.C(CCCCCCCC)(=O)OCC(C)OC(CCCCCCCC)=O LWDBKTVFHPCKHL-UHFFFAOYSA-N 0.000 description 1
- 101100459319 Arabidopsis thaliana VIII-2 gene Proteins 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 244000078958 Gardenia weissichii Species 0.000 description 1
- 206010019049 Hair texture abnormal Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical class C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 244000104275 Phoenix dactylifera Species 0.000 description 1
- 235000010659 Phoenix dactylifera Nutrition 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- INDXRDWMTVLQID-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO.OCCCCO INDXRDWMTVLQID-UHFFFAOYSA-N 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229940093528 cetearyl ethylhexanoate Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- NTLIJZACUWTZFB-UHFFFAOYSA-N dimethyl-[3-(octadecanoylamino)propyl]azanium;2-hydroxypropanoate Chemical compound CC(O)C(O)=O.CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C NTLIJZACUWTZFB-UHFFFAOYSA-N 0.000 description 1
- 229940079868 disodium laureth sulfosuccinate Drugs 0.000 description 1
- GLSRFBDXBWZNLH-UHFFFAOYSA-L disodium;2-chloroacetate;2-(4,5-dihydroimidazol-1-yl)ethanol;hydroxide Chemical compound [OH-].[Na+].[Na+].[O-]C(=O)CCl.OCCN1CCN=C1 GLSRFBDXBWZNLH-UHFFFAOYSA-L 0.000 description 1
- KHIQYZGEUSTKSB-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O.CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O KHIQYZGEUSTKSB-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- DAZXVJBJRMWXJP-UHFFFAOYSA-N n,n-dimethylethylamine Chemical compound CCN(C)C DAZXVJBJRMWXJP-UHFFFAOYSA-N 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940115476 ppg-1 trideceth-6 Drugs 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940096501 sodium cocoamphoacetate Drugs 0.000 description 1
- 229940079776 sodium cocoyl isethionate Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
Abstract
Description
1 Céramides ou pseudo-céramides quaternisés et les compositions1 Quaternized ceramides or pseudo-ceramides and compositions
cosmétiques en contenant La présente invention se rapporte au domaine de la chimie et plus particulièrement à la synthèse de sels d'ammonium quaternaires. The present invention relates to the field of chemistry and more particularly to the synthesis of quaternary ammonium salts.
La présente invention se rapporte à des composés correspondant à la formule (I) : O R2 O R4 R5 R1N 0 ^(n+R6 (I) X R3 Z- dans laquelle : - m et n sont, indépendamment l'un de l'autre, des nombres entiers choisis parmi les valeurs 0, 1,2et3; - p est un nombre entier choisi parmi les valeurs 1, 2 et 3 ; - X est choisi parmi l'hydrogène et une chaîne carbonée comportant de 1 à 4 atomes de carbone ; - RI est une chaîne carbonée, saturée ou insaturée, comportant de 4 à 25 atomes de carbone et éventuellement de 1 à 2 groupements hydroxyle ; - R2 est choisi parmi l'hydrogène et une chaîne alkyle comportant de 1 à 4 atomes de carbone, linéaire ou ramifiée, pouvant comporter un groupement hydroxyle ; - R3 est choisi parmi les groupements suivants : O Ry) R O tels que R est une chaîne carbonée, saturée ou insaturée, comportant de 4 à 25 atomes de carbone et éventuellement de 1 à 2 groupements hydroxyle ; - R4, R5 et R6 sont, indépendamment les uns des autres, un groupement alkyle comportant de 1 à 12 atomes de carbone, pouvant comporter des insaturations ou un groupement aromatique ; - Z est un halogène. The present invention relates to compounds corresponding to formula (I): ## STR2 ## wherein: m and n are, independently, one of the compounds of formula (I); other, integers selected from the values 0, 1,2 and 3; p is an integer selected from values 1, 2 and 3; X is selected from hydrogen and a carbon chain having 1 to 4 atoms; carbon - RI is a carbon chain, saturated or unsaturated, containing from 4 to 25 carbon atoms and optionally from 1 to 2 hydroxyl groups; R2 is chosen from hydrogen and an alkyl chain containing from 1 to 4 carbon atoms; carbon, linear or branched, which may comprise a hydroxyl group; R 3 is chosen from the following groups: ## STR3 ## where R is a carbon chain, saturated or unsaturated, containing from 4 to 25 carbon atoms and optionally from 1 to 2 hydroxyl groups; - R4, R5 and R6 are, independently of each other, an alkyl group having 1 to 12 carbon atoms, which may comprise unsaturations or an aromatic group; Z is a halogen.
La présente invention se rapporte également à la synthèse des composés de formule (I) par couplage entre une amine trisubstituée et un dérivé de céramide ou de pseudo-céramide. La présente invention se rapporte également à la réalisation de compositions cosmétiques contenant des composés de formule (I). The present invention also relates to the synthesis of the compounds of formula (I) by coupling between a trisubstituted amine and a ceramide or pseudo-ceramide derivative. The present invention also relates to the production of cosmetic compositions containing compounds of formula (I).
2909378 2 La présente invention se rapporte enfin à l'utilisation cosmétique des composés de formule (I) ou des compositions en contenant, plus particulièrement dans le domaine des soins capillaires et des shampooings.The present invention finally relates to the cosmetic use of the compounds of formula (I) or compositions containing them, more particularly in the field of hair care and shampoos.
5 En raison de leurs propriétés lavantes, les shampooings sont généralement formulés avec des tensioactifs anioniques. Or, ces derniers éliminent non seulement la saleté du cheveu, mais aussi les lipides naturels présents sur la surface des fibres capillaires. Ils laissent donc les cheveux dans des conditions peu satisfaisantes d'un point de vue cosmétique, avec notamment une dureté indésirable et un toucher sec.Due to their washing properties, shampoos are generally formulated with anionic surfactants. However, the latter not only remove the dirt from the hair, but also the natural lipids present on the surface of the hair fibers. They therefore leave the hair in unsatisfactory conditions from a cosmetic point of view, with in particular an undesirable hardness and a dry touch.
10 L'utilisation d'après-shampooings tend à combler ces effets négatifs et à nourrir le cheveu. Ces après-shampooings sont utilisés après application du shampooing et contiennent des composés cationiques destinés à compenser les effets des tensioactifs anioniques. De plus, la capacité des composés cationiques à interagir avec les molécules kératiniques du cheveu 15 facilite le démêlage des cheveux mouillés et confère une grande souplesse aux cheveux secs. Les composés cationiques sont donc nécessaires à un lavage et un traitement complet du cheveu (WO9924014, US 2002/0106343, W00234219). La présente invention se rapporte à des sels d'ammonium quaternaires de formule (I), dérivés de céramides naturels ou d'analogues de céramides, destinés à une application dans le domaine des soins capillaires.The use of conditioners tends to fill these negative effects and nourish the hair. These conditioners are used after application of the shampoo and contain cationic compounds to compensate for the effects of anionic surfactants. In addition, the ability of cationic compounds to interact with hair keratin molecules facilitates disentangling of wet hair and provides great flexibility to dry hair. The cationic compounds are therefore necessary for thorough washing and treatment of the hair (WO9924014, US 2002/0106343, WO 0234219). The present invention relates to quaternary ammonium salts of formula (I), derived from natural ceramides or ceramide analogues, for application in the field of hair care.
25 Les céramides figurent parmi les constituants lipidiques les plus importants du stratum corneum. Ils sont notamment des constituants des lipides naturels du cheveu, produits au niveau du bulbe pileux. Les céramides ou leurs analogues fonctionnels sont utilisés dans le domaine des soins capillaires pour réparer et renforcer les cheveux abîmés (EP1504747, FR2788689, US 2005/0160537, US1998/0153471).Ceramides are among the most important lipid constituents of the stratum corneum. They are in particular constituents of the natural lipids of the hair, produced at the level of the hair bulb. Ceramides or their functional analogues are used in the field of hair care to repair and strengthen damaged hair (EP1504747, FR2788689, US 2005/0160537, US1998 / 0153471).
30 Les sels d'ammonium quaternaires de formule (I) sont donc susceptibles d'associer les propriétés des céramides et des composés cationiques pour le soin et le traitement du cheveu. Les composés de formule (I) sont synthétisés selon l'invention à partir de céramides ou de 35 pseudo-céramides de formule (II) : O R2 20 RI dans laquelle : 2909378 3 - m et n sont, indépendamment l'un de l'autre, des nombres entiers choisis parmi les valeurs 0, 1,2 et 3; - X est choisi parmi l'hydrogène et une chaîne carbonée comportant de 1 à 4 atomes de carbone ; 5 - R1 est une chaîne carbonée, saturée ou insaturée, comportant de 4 à 25 atomes de carbone et éventuellement de 1 à 2 groupements hydroxyle ; - R2 est choisi parmi l'hydrogène et une chaîne alkyle comportant de 1 à 4 atomes de carbone, linéaire ou ramifiée, pouvant comporter un groupement hydroxyle ; - R3 est choisi parmi les groupements suivants : O )ÇR )OR ")\OR 10 O où R est une chaîne carbonée, saturée ou insaturée, comportant de, 4 à 25 atomes de carbone et éventuellement de 1 à 2 groupements hydroxyle. Les composés de formule (II) peuvent être des céramides naturels, comme par exemple ceux 15 représentés ci-dessous : OH Céramide II H33C1 O OH Céramide III 14H29 Céramide VI 14H29 20 Ils peuvent également être des composés de synthèse, analogues de céramides, comme par exemples ceux décrits dans le brevet EP 1644318. Selon une forme préférentielle de l'invention, ni est égal à 0 25 Selon une autre forme préférentielle de l'invention, m est égal à 1. Selon une forme préférentielle de l'invention, n est égal à 0 Selon une autre forme préférentielle de l'invention, n est égal à 1.The quaternary ammonium salts of formula (I) are therefore capable of associating the properties of ceramides and cationic compounds for the care and treatment of the hair. The compounds of formula (I) are synthesized according to the invention from ceramides or pseudo-ceramides of formula (II): ## STR2 ## wherein: ## STR2 ## wherein: other, integers selected from values 0, 1, 2 and 3; X is chosen from hydrogen and a carbon chain containing from 1 to 4 carbon atoms; R1 is a saturated or unsaturated carbon chain containing from 4 to 25 carbon atoms and optionally from 1 to 2 hydroxyl groups; - R2 is chosen from hydrogen and an alkyl chain comprising 1 to 4 carbon atoms, linear or branched, may include a hydroxyl group; R 3 is chosen from the following groups: ## STR1 ## where R is a saturated or unsaturated carbon chain containing from 4 to 25 carbon atoms and optionally from 1 to 2 hydroxyl groups. Compounds of formula (II) may be natural ceramides, such as those represented below: Ceramide II Ceramide III 14H29 Ceramide VI 14H29 They may also be synthetic compounds, ceramide analogues, as for example Examples of those described in patent EP 1644318. According to a preferred form of the invention, ni is equal to 0. According to another preferred form of the invention, m is equal to 1. According to a preferred form of the invention, n is equal to 0 According to another preferred form of the invention, n is equal to 1.
30 Selon une forme préférentielle de l'invention, X est un atome d'hydrogène. Selon une forme préférentielle de l'invention, R2 est un atome d'hydrogène.According to a preferred form of the invention, X is a hydrogen atom. According to a preferred form of the invention, R2 is a hydrogen atom.
2909378 4 Selon une forme préférentielle de l'invention, R3 est choisi parmi les groupements suivants : O yOR CO^R O où R est une chaîne carbonée, saturée ou insaturée, comportant de 4 à 25 atomes de carbone et éventuellement de 1 à 2 groupements hydroxyle, provenant d'un 5 acide gras ou d'un dérivé d'acide gras. Selon une forme préférentielle de l'invention, R4, R5 et R6 sont choisis, indépendamment les uns des autres, parmi les groupements méthyle, éthyle, propyle et butyle.According to a preferred form of the invention, R 3 is chosen from the following groups: ## STR2 ## where R is a carbon chain, saturated or unsaturated, comprising from 4 to 25 carbon atoms and optionally from 1 to 2 groups hydroxyl, derived from a fatty acid or a fatty acid derivative. According to one preferred form of the invention, R4, R5 and R6 are chosen, independently of one another, from methyl, ethyl, propyl and butyl groups.
10 Selon une autre forme préférentielle de l'invention, l'un au moins des groupements R4, R5 et R6 est un groupement lauryle. Selon une forme préférentielle de l'invention, Z est choisi parmi le brome et le chlore.According to another preferred form of the invention, at least one of the groups R4, R5 and R6 is a lauryl group. According to a preferred form of the invention, Z is chosen from bromine and chlorine.
15 Les composés de formule (I) sont synthétisés selon l'invention par un procédé en deux étapes, à partir d'un céramide naturel ou d'un analogue de céramide, pour obtenir un céramide, ou un analogue de céramide, quaternisé. Plusieurs procédés de quaternisation de molécules sont connus. Lindstedt et. al. font 20 référence à la synthèse de produits quaternisés de type alcools primaires (American Society for Microbiology, Antimicrobial agents and chemotherapy, Oct. 1990, 1949-1954). Ansgar et. al. (US2005054551) présentent la formation d'esters de bétaine à partir d' alkyle- ou alkylène-oligoglycosides. Plusieurs documents, comme US2005020474, décrivent la quaternisation d'amines tertiaires à l'aide d'halogénure d'alkyle.The compounds of formula (I) are synthesized according to the invention by a two-step process, starting from a natural ceramide or a ceramide analog, to obtain a ceramide, or a ceramide analog, quaternized. Several methods for quaternizing molecules are known. Lindstedt and. al. refer to the synthesis of quaternized products of the primary alcohol type (American Society for Microbiology, Antimicrobial agents and chemotherapy, Oct. 1990, 1949-1954). Ansgar and. al. (US2005054551) disclose the formation of betaine esters from alkyl- or alkylene-oligoglycosides. Several documents, such as US2005020474, describe the quaternization of tertiary amines using an alkyl halide.
25 Le procédé de synthèse selon l'invention correspond au schéma suivant : 2909378 O R2 R1 'n OH X R3 5 Etape 1 p=1,2ou3 (IV) Y= Br ou Cl Z= Brou Cl O R2 O Etape 2 N R4 R5R6 Y p (III) R1~\N 'nO~YZ p X R3 R2 O R4 \ ,R5 R1 ~\N O X R3 Z-(I) Schéma 1 On obtient comme produit intermédiaire l'haloester de formule (IV). Il s'agit d'un schéma 5 classique de quaternisation, notamment similaire à celui de Lindstedt et. al. (op. cit.). Toutefois, les conditions opératoires mises au point par la Demanderesse sont nouvelles et apportent une amélioration au procédé, notamment en terme d'exploitation à l'échelle industrielle.The synthesis method according to the invention corresponds to the following scheme: ## STR2 ## Step 1 p = 1.2 or 3 (IV) Y = Br or Cl Z = Br 2 Cl 2 O O Step 2 N R 4 R5R6 Y p (III) R1 ~ \ N 'nO ~ YZ p X R3 R2 O R4 \, R5 R1 ~ \ NOX R3 Z- (I) Scheme 1 The haloester of formula (IV) is obtained as an intermediate product. This is a classic quaternization scheme, in particular similar to that of Lindstedt et. al. (op cit). However, the operating conditions developed by the Applicant are new and provide an improvement to the process, especially in terms of exploitation on an industrial scale.
10 En effet, l'étape I de chloroacétylation nécessite habituellement un solvant halogéné, comme le chloroforme ou le dichlorométhane. Ces solvants posent des problèmes de toxicité pour l'application industrielle. De manière surprenante, la Demanderesse a mis au point un mode opératoire mettant en 15 oeuvre un solvant inerte non halogéné, notamment l'acétate d'éthyle. La deuxième étape de couplage peut également s'effectuer dans ce solvant. Non toxique et facilement accessible, l'acétate d'éthyle permet une adaptation aisée du procédé à grande échelle. Selon une forme préférentielle de l'invention, l'étape I s'effectue entre 10 et 70 C, plus 20 préférentiellement à température ambiante. Selon une forme préférentielle de l'invention, l'étape II s'effectue entre 25 et 75 C, plus préférentiellement autour de 50 C.Indeed, step I of chloroacetylation usually requires a halogenated solvent, such as chloroform or dichloromethane. These solvents pose toxicity problems for industrial application. Surprisingly, the Applicant has developed a procedure employing a non-halogenated inert solvent, especially ethyl acetate. The second coupling step can also be carried out in this solvent. Non-toxic and easily accessible, ethyl acetate allows easy adaptation of the process on a large scale. According to a preferred form of the invention, step I is carried out between 10 and 70 ° C., more preferably at room temperature. According to a preferred form of the invention, step II is carried out between 25 and 75 ° C., more preferably around 50 ° C.
25 De manière alternative, l'acétone peut être utilisée comme solvant lors de l'étape II. Toutefois, l'acétate d'éthyle sera employé préférentiellement. La présente invention se rapporte également à la réalisation de compositions cosmétiques contenant des composés de formule (I).Alternatively, acetone can be used as a solvent in step II. However, ethyl acetate will be used preferentially. The present invention also relates to the production of cosmetic compositions containing compounds of formula (I).
2909378 6 Selon une forme préférentielle de l'invention, la teneur des compositions en composés de formule (I) est de 0,001 à 20% par rapport au poids total de la composition.According to a preferred form of the invention, the content of the compositions of compounds of formula (I) is from 0.001 to 20% relative to the total weight of the composition.
5 Les compositions selon l'invention comprennent un support inerte, non toxique, cosmétiquement acceptable, en association ou en mélange avec le principe actif. Elles peuvent renfermer les adjuvants couramment utilisés dans le domaine cosmétique, comme par exemple des agents adoucissants, des gélifiants, des antioxydants, des solvants, des filtres, des conservateurs, des pigments ou des parfums.The compositions according to the invention comprise an inert, non-toxic, cosmetically acceptable carrier, in combination or in admixture with the active ingredient. They may contain adjuvants commonly used in the cosmetics field, such as, for example, softening agents, gelling agents, antioxidants, solvents, filters, preservatives, pigments or perfumes.
10 Les compositions selon l'invention se présentent sous une forme compatible avec l'application topique, comme une solution aqueuse, hydroalcoolique, hydroglycolique ou huileuse, une dispersion, une suspension, une émulsion huile dans eau ou eau dans huile, un gel aqueux ou huileux, une crème, un lait, une pommade, une lotion, une pâte, une mousse ou 15 un aérosol. Les compositions selon l'invention peuvent notamment se présenter sous la forme d'un shampooing, d'un après-shampooing, d'une lotion ou d'un baume capillaire, ou de toute autre composition pouvant être appliquée sur les cheveux ou le cuir chevelu. Les composés de formule (I) ou les compositions en contenant peuvent être utilisées sur le plan cosmétique, notamment dans le domaine des soins capillaires, afin de combiner les effets bénéfiques des agents cationiques et des céramides sur les cheveux et le cuir chevelu.The compositions according to the invention are in a form compatible with topical application, such as an aqueous, hydroalcoholic, hydroglycolic or oily solution, a dispersion, a suspension, an oil-in-water or water-in-oil emulsion, an aqueous gel or oily, cream, milk, ointment, lotion, paste, mousse or aerosol. The compositions according to the invention may especially be in the form of a shampoo, a conditioner, a lotion or a hair balm, or any other composition that can be applied to the hair or leather scalp. The compounds of formula (I) or compositions containing them may be used cosmetically, in particular in the field of hair care, in order to combine the beneficial effects of cationic agents and ceramides on the hair and scalp.
25 Exemples : Exemple I : Synthèse du pseudo-céramide ctuaternisé de formule (Ia) : O 20 NO H O,- Et H31C15 O 30 Le pseudo-céramide de départ, de formule (IIa) : O 0- H31015 0 Cl- (Ia) 2909378 7 peut être préparé selon la méthode décrite dans le brevet EP 1644318. Etape I : 1g du composé (IIa) est dissous dans 4 mL d'acétate d'éthyle. 1,2 équivalent de chlorure de chloroacétyle (CAS [79-04-9]) est ajouté goutte à goutte à température ambiante.EXAMPLES Example 1 Synthesis of the ctuaternized pseudo-ceramide of formula (Ia) ## STR16 ## The starting pseudo-ceramide of formula (IIa): ## STR2 ## ) Can be prepared according to the method described in patent EP 1644318. Step I: 1 g of the compound (IIa) is dissolved in 4 ml of ethyl acetate. 1.2 equivalents of chloroacetyl chloride (CAS [79-04-9]) is added dropwise at room temperature.
5 La réaction est agitée 24 heures à température ambiante. Le mélange réactionnel est ensuite lavé par 2 x 5 mL d'une solution aqueuse de NaHCO3 5% m/m puis par 2 x 5 mL d'eau. La phase organique est ensuite utilisée directement à l'étape suivante. Etape II : A température ambiante, 4 équivalents de triéthylamine (CAS [121-44-8D sont ajoutés goutte à goutte au mélange réactionnel, sur une durée totale de 20 minutes. Puis la 10 réaction est agitée à 50 C durant 48 heures. Après refroidissement, le mélange est concentré, le composé (Ia) est cristallisé dans l'acétone puis recristallisé dans l'acétate d'éthyle. Rendement : 60%. RMN'H (ppm) 8 0,81 (t, 6H, CH3); 1,11-1,28 (m, 38H, CH2); 1,30 (t, 9H, NCH2CH3); 1,36- 15 1,51 (m, 4H, CH2); 1,85-1,93 (m, 4H, CH2); 2,09-2,23 (m, 4H, CH2); 2,58-2,69 (m, 2H, CH2); 3,00-3,12 (m, 1H, CH); 3,67 (q, 6H, NCH2CH3); 4,07-4,29 (m, 4H, CH2); 5,02-5,42 (m, 6H, 4 CH= et CH2N+); 8,45 (t, 1H, NH). RMN13C (ppm) 8174,6 (NHC=O) ; 173,2 (C(=O)O) ; 164,6 (C(=O)O) ; 129,9 (2xCH=) ; 20 127,8 (2xCH=) ; 73,9 à 22,4 (CH2) ; 13,9 à 8,1 (CH3). Exemple II : Synthèse du pseudo-céramide quaternisé de formule (Ia') : O N/\ON Me H +I Et O, O Me CI H31C1s O 25 Le composé (Ia') est préparé selon un procédé similaire à celui de l'exemple I à partir du composé (IIa). A l'étape II, la triéthylamine est remplacée par de la diméthyléthylamine. La réaction est complète au bout de 6 heures d'agitation à 50 C. Exemple III : S thèse du seudo-céramide uaternisé de formule (lb) : O +Et O/ O Et 30 -131C1 -O CI 5 (lb) Le pseudo-céramide de départ, de formule (Ilb) : H 2909378 0 N H H31C15 O peut être préparé selon la méthode décrite dans le brevet EP 1644318. Le composé (lb) est préparé selon un procédé similaire à celui de l'exemple I à partir du 5 composé (I1h). Exemple IV : Synthèse du céramide quaternisé de formule (Ic) : O Cl- H25C1 2NH Et3N O OH 10 Le composé (Ic) est préparé selon un procédé similaire à celui de l'exemple I à partir du céramide II naturel. Exemple V : Synthèse du céramide quaternisé de formule (Id) : CI- H35C17 NH OH Et 3N O C14H29 15 O OH (Id) Le composé (Id) est préparé selon un procédé similaire à celui de l'exemple I à partir du céramide III naturel. Exemple VI : Synthèse du céramide quaternisé de formule (Ie) : 8 20 2909378 o H33C16NH OH O (le) Le composé (le) est préparé selon un procédé similaire à celui de l'exemple (I) à partir du céramide VI naturel.The reaction is stirred for 24 hours at room temperature. The reaction mixture is then washed with 2 × 5 mL of 5% aqueous NaHCO 3 solution / m 2 and then with 2 × 5 mL of water. The organic phase is then used directly in the next step. Step II: At room temperature, 4 equivalents of triethylamine (CAS [121-44-8D] are added dropwise to the reaction mixture over a total of 20 minutes, and the reaction is stirred at 50 ° C. for 48 hours. cooling, the mixture is concentrated, the compound (Ia) is crystallized from acetone and then recrystallized from ethyl acetate Yield: 60% 1H NMR (ppm) 0.81 (t, 6H, CH 3) 1.11-1.28 (m, 38H, CH 2); 1.30 (t, 9H, NCH 2 CH 3); 1.36-1.51 (m, 4H, CH 2); 1.85-1.93; (m, 4H, CH 2); 2.09-2.23 (m, 4H, CH 2); 2.58-2.69 (m, 2H, CH 2); 3.00-3.12 (m, 1H, CH), 3.67 (q, 6H, NCH2CH3), 4.07-4.29 (m, 4H, CH2), 5.02-5.42 (m, 6H, 4 CH = and CH2N +); 45 (t, 1H, NH) 13 C NMR (ppm) 8174.6 (NHC = O), 173.2 (C (= O) O), 164.6 (C (= O) O); EXAMPLE II Synthesis of Quaternized Pseudo-Ceramide of Formula (Ia ') The compound (Ia ') is prepared by the following formula: ## STR2 ## n a process similar to that of Example I from the compound (IIa). In step II, the triethylamine is replaced by dimethylethylamine. The reaction is complete after stirring for 6 hours at 50 ° C. EXAMPLE III: S thesis of the uterineized para-ceramide of formula (Ib): O + and O / O and 30 -131C1 -O Cl (Ib) starting pseudo-ceramide, of formula (IIb): ## STR1 ## may be prepared according to the method described in patent EP 1644318. Compound (Ib) is prepared according to a process similar to that of Example I at from the compound (I1h). EXAMPLE IV Synthesis of the Quaternized Ceramide of Formula (Ic): ## STR2 ## The compound (Ic) is prepared according to a process similar to that of Example I, starting with the natural ceramide II. EXAMPLE V Synthesis of the Quaternized Ceramide of Formula (Id): ## STR3 ## The compound (Id) is prepared according to a process similar to that of Example I starting from the ceramide Natural III. EXAMPLE VI Synthesis of the Quaternized Ceramide of Formula (Ie): The compound (Ie) is prepared according to a process similar to that of Example (I) from natural ceramide VI.
5 Exemple VII : Compositions contenant un sel d'ammonium quaternaire de formule (I) Exemple VII-1 : Masque capillaire INGREDIENTS NOMENCLATURE INCI 0o PHASE A ù Nikkomulese 61H Polyglyceryl-10 pentastearate / behenyl 2.00 alcohol / stearamidopropyl dimethylamine lactate _ Alcool béhénique Behenyl alcohol _ 3.00 Phényltriméthicone Phenyl trimethicone 3.00 Crodamol CAP Cetearyl ethylhexanoate / isopropyl myristate 2.00 Miglyol 812 Caprylic / capric triglyceride 2.00 Céramide quaternisé (Ia) _ 0.20 PHASE B _ Eau Aqua ù qs Butylène glycol Butylene glycol _ 1.50 Cosmedia Guar Guar h drox ro l trimonium chloride 0.30 PHASE C Glycolysat de datte Propylene glycol / Aqua / Phoenix dactylifera 3.00 C_yclométhicone Cyclomethicone 1.00 __-_ PHASE D .. Parfum _ 0.30 DC Yellow 6 CI 15985 qs Conservateur _ qs Rheocare CTH(E) Polyquaternium-37 / propylene glycol 0.75 dicaprylate/dicaprate / PPG-1 trideceth-6 9 OH CIEt3N 10 2909378 Exemple VII-2 : Soin capillaire INGREDIENTS NOMENCLATURE INCI % PHASE A Miglyol 812 Caprylic / capric triglyceride 2.00 Dipelargonate de propylène glycol Propylene glycol dipelargonate 3.00 Huile de pépins de raisin _ 1.00 Vitis vinifera (grape) seed oil Céramide quaternisé (la ^_ 0.50 PHASE B Eau Aqua ù qs Lait de larmes de bambou Aqua / Propylene glycol dicaprylate/dicaprate 0.50 /Bambusa vulgaris sap extract / Xanthan gum Rheocare CTH(E) Polyquaternium-37 / propylene glycol 1.50 dicaprylate/dicaprate / PPG-1 trideceth-6 PHASE C _ 0.20 Parfum FDC Red 40 _ qs CI 16035 Conservateur _ qs 5 Exemple VII-3 : Shampooing INGREDIENTS NOMENCLATURE INCI % PHASE A Eau _.. _û_ ..___.___ _Aqua__ qs __ P olyquaternium- 1 0 Polyquaternium-10 0.30 Gomme xanthane _ 0.20 Xanthan gum Glycérine Glycerin 1.30 _Benzophénone-4 Benzophenone-4 0.40 Lait de Monoï Tiaré , Aqua / Cocos nucifera / Gardenia tahitensis / 2.00 xanthan gum Lauryl sulfosuccinate de sodium Disodium laureth sulfosuccinate 10.00 Décyl glucoside _ 12.00 Decyl glucoside Cocoamphoacétate de sodium Sodium cocoamphoacetate ù 8.00 PHASE B Eau _ Aqua 30.00 Arlatone Duo ' _ 10.00 Disodium lauryl sulfosuccinate / Sodium cocoyl isethionate / Zea mays / Cetearyl alcohol / Aqua / Hydrogenated castor oil / Glycerin / Titanium dioxyde Céramide quaternisé (lb) 0.10 PHASE C Promidium 2 _ _ 2.25 PPG-2 Hydroxyethyl coco / isostearamide Parfum 0.30 Conservateur ___ _.__. . .__ _ qs FDC Red 40 ___- qs CI 16035 10EXAMPLE VII Compositions Containing a Quaternary Ammonium Salt of Formula (I) Example VII-1: Hair Mask INGREDIENTS NOMENCLATURE INCI 0o PHASE A - Nikkomulese 61H Polyglyceryl-10 pentastearate / behenyl 2.00 alcohol / stearamidopropyl dimethylamine lactate - Behenyl alcohol Behenyl alcohol 3.00 Phenyltrimethicone Phenyl trimethicone 3.00 Crodamol CAP Cetearyl ethylhexanoate / isopropyl myristate 2.00 Miglyol 812 Caprylic / capric triglyceride 2.00 Quaternized ceramide (Ia) _ 0.20 PHASE B _ Aqua water ù qs Butylene glycol Butylene glycol _ 1.50 Cosmedia Guar Guar H ux ro l trimonium chloride 0.30 PHASE C Date Glycolysate Propylene glycol / Aqua / Phoenix dactylifera 3.00 Cyclomethicone Cyclomethicone 1.00 __-_ PHASE D .. Perfume _ 0.30 DC Yellow 6 CI 15985 qs Preservative _ qs Rheocare CTH (E) Polyquaternium-37 / propylene glycol 0.75 dicaprylate / Example VIII-2: Hair Care INGREDIENTS NOMENCLATUR E INCI% PHASE A Miglyol 812 Caprylic / Capric Triglyceride 2.00 Propylene Glycol Dipelargonate Propylene Glycol Dipelargonate 3.00 Grape Seed Oil _ 1.00 Vitis vinifera (grape) seed oil Quaternized Ceramide (the _ _ 0.50 PHASE B Aqua Water ù qs Milk of Tears of bamboo Aqua / Propylene glycol dicaprylate / dicaprate 0.50 / Bambusa vulgaris extract sap / Xanthan gum Rheocare CTH (E) Polyquaternium-37 / propylene glycol 1.50 dicaprylate / dicaprate / PPG-1 trideceth-6 PHASE C _ 0.20 Fragrance FDC Red 40 _ qs CI 16035 Preservative Example VII-3: Shampoo INGREDIENTS NOMENCLATURE INCI% PHASE A Water _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Polyquaternium-10 0.30 Xanthan gum _ 0.20 Xanthan gum Glycerin Glycerin 1.30 _Benzophenone -4 Benzophenone-4 0.40 Tiare Monoi Milk, Aqua / Cocos nucifera / Gardenia tahitensis / 2.00 xanthan gum Lauryl sodium sulfosuccinate Disodium laureth sulfosuccinate 10.00 Decyl glucoside _ 12.00 Decyl glucoside Cocoamph sodium oacetate Sodium cocoamphoacetate ù 8.00 PHASE B Water _ Aqua 30.00 Arlatone Duo '_ 10.00 Disodium lauryl sulphosuccinate / Sodium cocoyl isethionate / Zea mays / Cetearyl alcohol / Aqua / Hydrogenated castor oil / Glycerin / Titanium dioxide Quaternized ceramide (lb) 0.10 PHASE C Promidium 2 _ _ 2.25 PPG-2 Hydroxyethyl coco / isostearamide Fragrance 0.30 Preservative ___ _.__. . FDC Red 40 ___-qs CI 16035 10
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0610602A FR2909378B1 (en) | 2006-12-05 | 2006-12-05 | CERAMIDES OR PESUDO-CERAMIDES FOURERNISES AND COSMETIC COMPOSITIONS CONTAINING SAME |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0610602A FR2909378B1 (en) | 2006-12-05 | 2006-12-05 | CERAMIDES OR PESUDO-CERAMIDES FOURERNISES AND COSMETIC COMPOSITIONS CONTAINING SAME |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2909378A1 true FR2909378A1 (en) | 2008-06-06 |
FR2909378B1 FR2909378B1 (en) | 2012-01-13 |
Family
ID=38162299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0610602A Expired - Fee Related FR2909378B1 (en) | 2006-12-05 | 2006-12-05 | CERAMIDES OR PESUDO-CERAMIDES FOURERNISES AND COSMETIC COMPOSITIONS CONTAINING SAME |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2909378B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2926725A1 (en) * | 2008-01-25 | 2009-07-31 | Biochimie Appliquee Sa Soc | Cosmetic and/or dermatological composition, useful for promoting skin healing, comprises polyunsaturated fatty acid compound as an active ingredient, in combination with an excipient and/or a carrier for topical application |
FR2944973A1 (en) * | 2009-05-04 | 2010-11-05 | Biochimie Appliquee Solabia So | New quaternary ammonium salts useful for the treatment of hair and in the form of milk, cream, lotion, shampoo, masks or hair care preparations |
JP2016121174A (en) * | 2010-06-03 | 2016-07-07 | アルニラム・ファーマシューティカルズ・インコーポレーテッド | Biodegradable lipids for delivery of active agents |
WO2018118160A1 (en) * | 2016-12-22 | 2018-06-28 | L'oreal | Cosmetic compositions for treating keratinous substrates |
US11246933B1 (en) | 2011-12-07 | 2022-02-15 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2679770A1 (en) * | 1991-08-01 | 1993-02-05 | Oreal | Cationic dispersions for treatment of the hair or skin based on ceramides and/or glycoceramides, cosmetic compositions containing them and their cosmetic applications |
EP0704200A1 (en) * | 1994-09-29 | 1996-04-03 | L'oreal | Cosmetic compositions containing a lipid ceramide-type compound and a peptide with a fatty chain |
WO2004108659A1 (en) * | 2003-06-03 | 2004-12-16 | Societe La Biochimie Appliquee Solabia | New method for synthesizing ceramide-type compounds |
-
2006
- 2006-12-05 FR FR0610602A patent/FR2909378B1/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2679770A1 (en) * | 1991-08-01 | 1993-02-05 | Oreal | Cationic dispersions for treatment of the hair or skin based on ceramides and/or glycoceramides, cosmetic compositions containing them and their cosmetic applications |
EP0704200A1 (en) * | 1994-09-29 | 1996-04-03 | L'oreal | Cosmetic compositions containing a lipid ceramide-type compound and a peptide with a fatty chain |
WO2004108659A1 (en) * | 2003-06-03 | 2004-12-16 | Societe La Biochimie Appliquee Solabia | New method for synthesizing ceramide-type compounds |
EP1644318A1 (en) * | 2003-06-03 | 2006-04-12 | Société La Biochimie Appliquée - SO.LA.BI.A. | New method for synthesizing ceramide-type compounds |
Non-Patent Citations (1)
Title |
---|
S.A. NOVGORODOV ET AL.: "Positively Charged Ceramide is a Potent Inducer of Mitochondrial Permeabilization", JOURNAL OF BIOLOGICAL CHEMISTRY (ONLINE), vol. 280, no. 16, 22 April 2005 (2005-04-22), USAMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, BETHESDA, MD,, pages 16096 - 16105, XP002439578 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2926725A1 (en) * | 2008-01-25 | 2009-07-31 | Biochimie Appliquee Sa Soc | Cosmetic and/or dermatological composition, useful for promoting skin healing, comprises polyunsaturated fatty acid compound as an active ingredient, in combination with an excipient and/or a carrier for topical application |
FR2944973A1 (en) * | 2009-05-04 | 2010-11-05 | Biochimie Appliquee Solabia So | New quaternary ammonium salts useful for the treatment of hair and in the form of milk, cream, lotion, shampoo, masks or hair care preparations |
JP2016121174A (en) * | 2010-06-03 | 2016-07-07 | アルニラム・ファーマシューティカルズ・インコーポレーテッド | Biodegradable lipids for delivery of active agents |
US11246933B1 (en) | 2011-12-07 | 2022-02-15 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
US11382979B2 (en) | 2011-12-07 | 2022-07-12 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
US11400158B2 (en) | 2011-12-07 | 2022-08-02 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
US11612657B2 (en) | 2011-12-07 | 2023-03-28 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
US11633480B2 (en) | 2011-12-07 | 2023-04-25 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
US11633479B2 (en) | 2011-12-07 | 2023-04-25 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
US11679158B2 (en) | 2011-12-07 | 2023-06-20 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
WO2018118160A1 (en) * | 2016-12-22 | 2018-06-28 | L'oreal | Cosmetic compositions for treating keratinous substrates |
Also Published As
Publication number | Publication date |
---|---|
FR2909378B1 (en) | 2012-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1059436A (en) | Quarternary polymers based cosmetic agents_ | |
EP0526267B1 (en) | Polyfluoroalkylthiopoly(ethylimidazolium) compounds, process for their preparation, and their use as biocidal agents | |
KR100300816B1 (en) | N-acylamino acid esters and hair or wool agents using the same | |
FR2889448A1 (en) | COSMETIC COMPOSITION COMPRISING FATTY CHAIN POLYLYSINS, FOR IMPROVING THE SURFACE CONDITION OF KERATIN FIBERS | |
CA1167070A (en) | Surface-active nonionic polyoxyethylenes containing two lipophilic chains, their preparation and compositions containing these products | |
FR2732680A1 (en) | CERAMIDE-LIKE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE THEREOF | |
CH622698A5 (en) | ||
FR2840903A1 (en) | Glucose fatty acid esters active in preventing hair loss and aiding hair regrowth | |
FR2672288A1 (en) | NOVEL GLYCYL-SERINE DIPEPTIDE DERIVATIVES, USED IN PARTICULAR IN COSMETIC, PHARMACEUTICAL OR FOOD COMPOSITIONS. | |
FR2909378A1 (en) | New (pseudo)ceramide compounds useful in the field of hair care, like shampoos, after-shampoos, lotions or hair balms | |
EP2249780A2 (en) | Cationic surfactant compounds, use thereof as conditioner, cosmetic treatment method, and cosmetic or pharmaceutical compositions comprising same | |
EP0408448B1 (en) | Urethane derivatives, their preparation and their use as humectants in cosmetic and pharmaceutical compositions for the treatment of dry skin | |
CA1074497A (en) | Quaternized polymers and process for their preparation | |
EP0577506B1 (en) | Use of aminopolyol carbamates as thickeners in solutions of surface active agents | |
CA1134824A (en) | Cosmetic composition for the treatment of seborrhea, novel composition and preparation process | |
EP0705599B1 (en) | Use of N-(hydroxyalkyl)-substituted alkyl carbamates as tensioactive agents in cosmetic composition | |
WO1999046280A1 (en) | Lipid compounds derived from sphingoid bases, preparation method and uses in cosmetics and dermopharmacy | |
FR2778917A1 (en) | NOVEL HISTIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND USES | |
FR2982485A1 (en) | Cosmetic composition, useful e.g. as a caring, cleansing and/or makeup product for skin of body or face, lips, eyebrows, lashes, nails and hair, or an antisun or self-tanning product, comprises a new or know lysine derivative in a medium | |
FR2756824A1 (en) | HYDROXYPROPYL QUATERNARY AMMONIUM DERIVATIVES WITH ESTER FUNCTION, COSMETIC AND DERMATOLOGICAL COMPOSITIONS CONTAINING SAME | |
EP0498729B1 (en) | Dipeptide derivatives with urethan groupings, their preparation and their application, especially as hydratating agents and tensioactive agents in cosmetic, pharmaceutical and alimentary preparations | |
FR2982486A1 (en) | Cosmetic composition, useful e.g. as caring, cleansing and/or makeup product for skin of body or face, lips, eyebrows, lashes, nails and hair, or antisun or self-tanning products, comprises a new or know lysine derivative in a medium | |
FR2964864A1 (en) | Cosmetic treatment of keratin materials comprises applying a cosmetic composition comprising at least one ortho-diphenol compound to the keratin materials | |
FR3036034A1 (en) | COMPOSITION COMPRISING SALICYLIC ACID DERIVATIVES AND A PARTICULATE SOLVENT | |
FR2964866A1 (en) | Use of new of known at least one ortho-diphenol compound as antidandruff agent to treat dandruff associated with the proliferation of Malassezia yeasts on the scalp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20081020 |
|
RN | Application for restoration | ||
FC | Decision of inpi director general to approve request for restoration | ||
PLFP | Fee payment |
Year of fee payment: 10 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 14 |
|
PLFP | Fee payment |
Year of fee payment: 15 |
|
PLFP | Fee payment |
Year of fee payment: 16 |
|
PLFP | Fee payment |
Year of fee payment: 17 |
|
PLFP | Fee payment |
Year of fee payment: 18 |